The conundrum of Metlifecare's discount while peers trade at a premium

The conundrum of Metlifecare's discount while peers trade at a premium
Jenny Ruth
By Jenny Ruth March 27 (BusinessDesk) - Why do Metlifecare shares trade at less than 70 cents in the dollar compared with its net tangible asset backing and yet shares in competitors such as Ryman Healthcare and Summerset Group trade at huge premiums to NTA? Ryman is currently trading at $11.76, nearly three times its $4.056 NTA at Sept. 30, while Summerset shares are trading at $6.36, 46.5 percent higher than their $4.34 NTA at Dec. 30, but Metlifecare is trading at $4.79 compared to its Dec. 30 NTA of $6.97. Stuart Williams, head of...